📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Developing therapies for Parkinson's disease. (2020)

First Author: The Lancet Neurology

Attributed to: Cellular and molecular insights into neurodegeneration mediated by the C9orf72 gene mutation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(20)30320-3

PubMed Identifier: 32949529

Publication URI: http://europepmc.org/abstract/MED/32949529

Type: Journal Article/Review

Volume: 19

Parent Publication: The Lancet. Neurology

Issue: 10

ISSN: 1474-4422